Zebra Capital Management LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zebra Capital Management LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$256
-25.6%
6,695
+10.8%
1.28%
+6.3%
Q4 2022$344
-99.8%
6,042
+14.9%
1.20%
+51.9%
Q3 2022$208,000
-31.4%
5,257
-23.6%
0.79%
-11.0%
Q2 2022$303,000
+21.2%
6,877
+9.7%
0.89%
+55.1%
Q1 2022$250,000
-8.1%
6,267
-7.3%
0.57%
+32.0%
Q4 2021$272,000
-27.7%
6,761
-26.9%
0.44%
-4.4%
Q3 2021$376,000
-11.5%
9,254
-1.0%
0.46%
-8.6%
Q2 2021$425,000
-1.6%
9,350
-9.7%
0.50%
+4.6%
Q1 2021$432,000
+104.7%
10,359
-23.3%
0.48%
+106.1%
Q3 2019$211,00013,5000.23%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders